Furthermore, we investigated the underlying functions of SIGLEC9 in glioma pathogenesis, and we found that SIGLEC9 might regulate the TME to induce tumor growth, metastasis, and the therapy resistance of gliomas. Here, SIGLEC9 is linked to neoplasm.